2017
DOI: 10.1101/232900
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Correcting for population stratification reduces false positive and false negative results in joint analyses of host and pathogen genomes

Abstract: Studies of host genetic determinants of pathogen sequence variation can identify sites of genomic conflicts, by highlighting variants that are implicated in immune response on the host side and adaptive escape on the pathogen side. However, systematic genetic differences in host and pathogen populations can lead to inflated type I (false positive) and type II (false negative) error rates in genome-wide association analyses. Here, we demonstrate through simulation that correcting for both host and pathogen stra… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 33 publications
(30 reference statements)
0
2
0
Order By: Relevance
“…The use of a mixed effects association model allows to account for population stratification of the host genome. To control for population stratification among EBV genomes, we included the first six principal components (PCs) of EBV genetic variation to the covariate matrix X [59]. Other covariates were sex, age and EBV type.…”
Section: Methodsmentioning
confidence: 99%
“…The use of a mixed effects association model allows to account for population stratification of the host genome. To control for population stratification among EBV genomes, we included the first six principal components (PCs) of EBV genetic variation to the covariate matrix X [59]. Other covariates were sex, age and EBV type.…”
Section: Methodsmentioning
confidence: 99%
“…A preprint version of this article is available on biorxiv (Naret et al, 2018). We would like to acknowledge the members of the Swiss HIV Cohort Study: Anagnostopoulos A, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Calmy A, Cavassini M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, JF, Furrer H (Chairman of the Clinical and Laboratory Committee), Fux CA, Günthard HF (President of the SHCS), Haerry D (deputy of Positive Council), Hasse B, Hirsch HH, Hoffmann M, Hösli I, Huber M, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner KJ, Müller N, Nicca D, Paioni P, Pantaleo G, Perreau M, Rauch A (Chairman of the Scientific Board), Rudin C (Chairman of the Mother & Child Substudy), Scherrer AU (Head of Data Centre), Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Wandeler G, Weber R, Yerly S.…”
mentioning
confidence: 99%